Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Qijie Ran"'
Autor:
Pengyun Li, Xiaotong Hu, Zhiya Fan, Shiyang Sun, Qijie Ran, Ting Wei, Pengli Wei, Qiyu Jiang, Jian Yan, Ning Yang, Changkai Jia, Tingting Yang, Yaqiu Mao, Xu Cai, Tingting Xu, Zhiyuan Zhao, Xiaohong Qian, Weijie Qin, Xiaomei Zhuang, Feng Fan, Junhai Xiao, Zhibing Zheng, Song Li
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-30 (2024)
Abstract Background Targeted protein degradation of neosubstrates plays a crucial role in hematological cancer treatment involving immunomodulatory imide drugs (IMiDs) therapy. Nevertheless, the persistence of inevitable drug resistance and hematolog
Externí odkaz:
https://doaj.org/article/53485170677d439b9bf56471960e9a2e
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Objectives Circular RNA_0003489 (Circ_0003489) promotes multiple myeloma (MM) progression and bortezomib resistance in MM cells, while its potential as a biomarker in newly diagnosed MM (NDMM) patients is unclear. Thus, this study aimed to investigat
Externí odkaz:
https://doaj.org/article/ae636722724849e9bd61d821bf729da8
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Multiple myeloma has a long course, with no obvious symptoms in the early stages. However, advanced stages are characterized by injury to the bone system and represent a severe threat to human health. The results of the present work indicate that the
Externí odkaz:
https://doaj.org/article/649ab6d459ca4b9293068ad91aab0c9b
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0236124 (2020)
The gene expression for interleukin-2 receptor subunit alpha (CD25/IL2RA) is frequently altered in adults with acute myeloid leukemia (AML). Increasing evidence indicates that the elevated expression of CD25 may be correlated with poor survival for A
Externí odkaz:
https://doaj.org/article/27ee9a88a4c24ae89339070d58eedc39
Publikováno v:
Irish Journal of Medical Science (1971 -). 192:561-567
The anti-tumor effect of polo-like kinase 4 (PLK4) inhibitor has been explored in several neoplasms, while its synergy with bortezomib in multiple myeloma (MM) remains elusive. Hence, the present study aimed to investigate the effect of PLK4 inhibito
Autor:
Qiaomei Liu, Li Chen, Wenxiang Ren, Fang Dong, Di Wu, Qijie Ran, Robert Peter Gale, Lei Chen, Hongxiang Wang, Wenlan Chen, Qiubai Li, Yu Hu, Liling Cai, Jianming Yu, Zhichao Chen, Fei Gao, Lei Li, Yulin Cao, Qin Li, Wenjuan He
Publikováno v:
Leukemia
The impact of cancer on outcome of persons with coronavirus disease 2019 (COVID-19) after infection with acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is controversial. We studied 1859 subjects with COVID-19 from seven centers in Wuhan, China
Publikováno v:
Frontiers in oncology. 12
Multiple myeloma has a long course, with no obvious symptoms in the early stages. However, advanced stages are characterized by injury to the bone system and represent a severe threat to human health. The results of the present work indicate that the
Autor:
Qiubai, Li, Lei, Chen, Qin, Li, Wenjuan, He, Jianming, Yu, Li, Chen, Yulin, Cao, Wenlan, Chen, Di Wu, Fang, Dong, Liling, Cai, Qijie, Ran, Lei, Li, Qiaomei, Liu, Wenxiang, Ren, Fei, Gao, Hongxiang, Wang, Zhichao, Chen, Robert Peter, Gale, Yu, Hu
Publikováno v:
Leukemia
The impact of cancer on outcome of persons with coronavirus disease 2019 (COVID-19) after infection with acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is controversial. We studied 1859 subjects with COVID-19 from seven centers in Wuhan, China
Autor:
Li Chen, Di Wu, Hongxiang Wang, Yu Hu, Wenxiang Ren, Lei Chen, Fei Gao, Qiubai Li, Lei Li, Weiqun Chen, Yulin Cao, Qijie Ran, Wenlan Chen, Fang Dong, Jianming Yu, Zhichao Chen, Robert Peter Gale, Qiaomei Liu, Wenjuan He
Publikováno v:
Leukemia
We studied admission and dynamic demographic, hematological and biochemical co-variates in 1449 hospitalized subjects with coronavirus infectious disease-2019 (COVID-19) in five hospitals in Wuhan, Hubei province, China. We identified two admission c
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0236124 (2020)
PLoS ONE
PLoS ONE
The gene expression for interleukin-2 receptor subunit alpha (CD25/IL2RA) is frequently altered in adults with acute myeloid leukemia (AML). Increasing evidence indicates that the elevated expression of CD25 may be correlated with poor survival for A